Form 13-F position report

CVS HEALTH CORPORATION (DE)

Reported by CHIRON CAPITAL MANAGEMENT LLC

Company profile Manager portfolio Source filing
CVS CUSIP 126650100 Manager CIK 0001830922
Latest reported change

Reported 22,600 shares, up 14,800 (189.7%) from the prior quarter.

Reported value 169.5%; share count 189.7% vs. the prior quarter.

Added
% of reported 13F value 1.24% This manager · Q2 2023
Shares 22,600 Quarter-end amount reported
Reported value $1,562,338 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q3 2026 Reduced 0 -2,579 (-100.0%) 0 $0 2026-10-15
Q2 2026 New 2,579 +2,579 (0.0%) 0.24% $266,798 2026-07-21
Q1 2026 Reduced 0 -14,206 (-100.0%) 0 $0 2026-04-21
Q3 2025 Reduced 14,206 -372 (-2.6%) 0.92% $1,070,990 2025-11-14
Q2 2025 Reduced 14,578 -750 (-4.9%) 0.87% $1,005,590 2025-08-11
Q1 2025 Reduced 15,328 -10,402 (-40.4%) 0.94% $1,038,472 2025-05-15
Q4 2024 Reduced 25,730 -14,800 (-36.5%) 1.09% $1,155,020 2025-02-13
Q3 2024 Reduced 40,530 -1,097 (-2.6%) 2.26% $2,548,526 2024-11-14
Q2 2024 Added 41,627 +17,642 (73.6%) 2.35% $2,458,491 2024-08-08
Q1 2024 Reduced 23,985 -4,568 (-16.0%) 1.74% $1,913,044 2024-05-10
Q4 2023 Added 28,553 +753 (2.7%) 1.96% $2,254,545 2024-02-12
Q3 2023 Added 27,800 +5,200 (23.0%) 1.67% $1,940,996 2023-11-14
Q2 2023 Added 22,600 +14,800 (189.7%) 1.24% $1,562,338 2023-07-27
Q1 2023 New 7,800 +7,800 (0.0%) 0.4% $579,618 2023-04-21
Q1 2022 Reduced 0 -6,370 (-100.0%) 0 $0 2022-04-18
Q4 2021 Reduced 6,370 -400 (-5.9%) 0.47% $657,000 2022-01-18
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

2383 managers reported CVS HEALTH CORPORATION (DE) for Q2 2023.

Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 116,676,882 +341,411 0.19% $8,065,872,853 41 qtrs
BlackRock Inc Added 93,734,850 +261,789 0.18% $6,479,890,168 41 qtrs
STATE STREET CORPORATION Added 55,877,387 +855,269 0.2% $3,862,803,763 41 qtrs
MORGAN STANLEY Added 33,253,424 +1,982,929 0.23% $2,298,809,478 41 qtrs
Capital World Investors Reduced 30,490,802 -2,143,168 0.41% $2,107,829,055 16 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 23,325,287 +363,384 0.19% $1,607,886,146 41 qtrs
FMR LLC Added 21,292,797 +7,625,848 0.12% $1,471,971,086 41 qtrs
Invesco Ltd Added 17,002,487 +1,605,878 0.31% $1,175,381,938 41 qtrs
Bank of America Corporation Reduced 16,551,119 -1,373,918 0.12% $1,144,178,923 41 qtrs
Dodge & Cox Added 16,024,422 +3,417,573 0.74% $1,107,768,293 20 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
July 27, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
0
None
22,600

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.